The journey of a successful medicine from discovery through development, to the treatment of patients is a long and complex process. One crucial aspect of this is the manufacture of the active pharmaceutical ingredient (API), with ever increasing quantities required from initially grams for safety testing, up to potentially thousands of kilograms for a commercial marketed medicine.
This talk will provide a general overview of the development process. More detailed stories from the laboratory synthesis of potential medicines currently in the early stages of development, up to the large-scale manufacture of more advanced projects in a specialised Pilot Plant will also be shared. Focus and comparison on the changing technical, safety, accommodation and regulatory challenges during this journey will offer an engaging insight for all those interested in how medicines are made.
Dr James Douglas, AstraZeneca UK
Abi Thorne, AstraZeneca UK
Time: 18:00 for 18:30
Merck Sharp & Dohme
2 Pancras Square
This is a free event but please register to book your place.
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email email@example.com for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.